益盛药业：10月24日召开董事会会议

Group 1 - Yisheng Pharmaceutical (SZ 002566) announced on October 26 that its ninth board meeting was held on October 24, 2025, to review proposals regarding the revision and formulation of certain governance systems [1] - For the first half of 2025, Yisheng Pharmaceutical's revenue composition was as follows: 81.06% from the pharmaceutical industry, 10.27% from health products and others, 7.39% from cosmetics, and 1.28% from other sources [1] - As of the report date, Yisheng Pharmaceutical's market capitalization was 2.7 billion yuan [1]